# Codex Review: medical_monitoring_phase_c8_adapter_consumer_coverage_20260802

Date: 2026-08-02 01:44 CST
Execution: Codex direct; no Hermes route, conference or sub-agent was used.

Changed source/test/evidence:
- `services/api/app/monitoring_adapter_consumer_coverage.py`
- `tests/test_monitoring_adapter_consumer_coverage.py`
- `runs/execution/medical_monitoring_phase_c8_adapter_consumer_coverage_20260802/build_coverage_matrix.py`
- `runs/execution/medical_monitoring_phase_c8_adapter_consumer_coverage_20260802/ADAPTER_CONSUMER_COVERAGE_MATRIX.json`

## Verdict

Pass for the review-only adapter source-to-consumer coverage matrix. It is not
medical mapping approval, adapter activation, source parsing, runtime registry
work, browser acceptance or a commercial release decision.

## Boundary Check

- The matrix consumes only the existing C3 review-only inventory and typed
  observations. It never opens a real listing/protocol, invokes an adapter,
  writes a registry/API/runtime store or starts a service.
- Every observation retains adapter/project/trial, source sheet/field, evidence
  locator, capability, recommended role, original domain label and review-only
  status. `activation_allowed` is fixed false and the risk policy is fixed at
  `explicit_risk_instance_id_only`.
- Explicit domain policy gives all observations Timeline/Profile coverage; only
  AE/LAB/VITALS/ECG receive a safety-metric surface. `SOURCE` and
  `BACKGROUND_TREATMENT` are deliberately normalized to `OTHER` while retaining
  the original label, so they cannot be mistaken for IP or CM.
- Required event/observation fields cover identity, date precision/raw date,
  visit, evidence, values/missingness, rules, completeness and uncertainty.
  Unknown domains, non-review status, surface overclaim, duplicate identity and
  activation attempts fail closed.

## Codex Verification

- C8 focused tests: **4 passed**.
- C1-C8 Python contract suite: **65 passed**.
- `python3 -m py_compile` and `python3 -m ruff check` passed for the C8 module,
  test and matrix builder.
- The generated matrix reproduced all **46 C3 observations**: RUX 11, MY009
  18 and MG-K10 17; all three plan hashes matched the source inventory.
- Matrix SHA-256: `ce7dd80adc1806ef9ffaf22dd1a1f8a5f63e571125aa93e6d4c5c76e1714983d`.
- Source SHA-256: `5c2501a691beb4587e04c8d041dbaae8fd78e1258bb239a4be04783f6d3c9a42`.
- Test SHA-256: `f4c27945b7157e41d684bffb6867c9eec09daa065b8c38629f7048175d09da7f`.
- No browser/PPT/PDF/live-authority check was applicable; no service, adapter,
  database, AI or real-project run occurred.

## Independent Review

- No delegated output exists because the user required Codex-direct execution.
  The matrix was reviewed against C3 mapping semantics, C4/C5/C6/C7 contracts
  and the three named skill requirements for source/date/visit/evidence fidelity.
- The two non-clinical observed labels were treated conservatively as `OTHER`
  with original labels retained; no treatment identity or risk category was
  inferred from their names.

## Residual Risk

- C8 does not prove that any source sheet/field is medically correct or that an
  adapter can populate the required fields from real data. C3 remains
  `observed_requires_medical_review`; B6/B4 authority blockers remain open.
- Timeline/Profile/UI wiring, browser rendering, real source evidence,
  canonical risk authority, persistence, permissions, migration, performance
  and real-project medical acceptance are pending.
- Next safe action: C9 source-bound read-only fixture validation after explicit
  mapping review, still with no runtime registration or service startup.
